Enhanced Expression of the Human Gene N-myc Consequent to Amplification of DNA May Contribute to Malignant Progression of Neuroblastoma
Overview
Affiliations
Previous studies had revealed that DNA with partial similarity to the myc oncogene (N-myc) is frequently amplified in human neuroblastoma cell lines and neuroblastoma tumors. We show here for one patient that N-myc amplification is confined to the neuroblastoma tumor and is not present in normal tissue. N-myc mRNA approximately equal to 4.0 kilobases in size is detectable in neuroblastoma cell lines and tumors and in a retinoblastoma cell line. By contrast, appreciable amounts of this RNA were not present in a number of cell lines derived from other human tumors and in fibroblasts from a normal individual and from a neuroblastoma patient. Low levels of N-myc RNA were found in human and murine neuroblastoma cell lines lacking amplification of this gene, up to 80-fold greater levels in all cell lines carrying amplified N-myc. In situ hybridization to sections of neuroblastoma tumors revealed high expression of N-myc predominantly in undifferentiated neuroblasts. We hypothesize that amplification and consequent elevated expression of N-myc may be related to malignant progression.
Loss of ARID1A leads to a cold tumor phenotype via suppression of IFNγ signaling.
Watson P, DeVaux C, Freeman K Sci Rep. 2025; 15(1):8716.
PMID: 40082458 PMC: 11906763. DOI: 10.1038/s41598-025-91688-4.
The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres.
Graham M, Xu B, Davis C, Meeker A, Heaphy C, Yegnasubramanian S Cancer Res Commun. 2024; 4(6):1533-1547.
PMID: 38837897 PMC: 11188873. DOI: 10.1158/2767-9764.CRC-22-0287.
Nakatani K, Kogashi H, Miyamoto T, Setoguchi T, Sakuma T, Kugou K Front Oncol. 2024; 14:1237378.
PMID: 38390263 PMC: 10882222. DOI: 10.3389/fonc.2024.1237378.
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.
Pusch F, Dorado Garcia H, Xu R, Gurgen D, Bei Y, Bruckner L Mol Cancer Ther. 2023; 23(4):507-519.
PMID: 38159110 PMC: 10985474. DOI: 10.1158/1535-7163.MCT-23-0094.
Metastasis in neuroblastoma: the question.
Bhavsar S Front Oncol. 2023; 13:1196861.
PMID: 37274289 PMC: 10233040. DOI: 10.3389/fonc.2023.1196861.